- Home
- IOTR vs COEP Comparison
IOTR vs COEP Comparison
Compare IOTR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- COEP
- Stock Information
- Founded
- IOTR 2019
- COEP 2017
- Country
- IOTR Singapore
- COEP United States
- Employees
- IOTR N/A
- COEP N/A
- Industry
- IOTR
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IOTR
- COEP Health Care
- Exchange
- IOTR NYSE
- COEP Nasdaq
- Market Cap
- IOTR 11.5M
- COEP 27.4M
- IPO Year
- IOTR 2025
- COEP N/A
- Fundamental
- Price
- IOTR $0.47
- COEP $10.92
- Analyst Decision
- IOTR
- COEP
- Analyst Count
- IOTR 0
- COEP 0
- Target Price
- IOTR N/A
- COEP N/A
- AVG Volume (30 Days)
- IOTR 693.0K
- COEP 55.9K
- Earning Date
- IOTR 01-01-0001
- COEP 08-15-2025
- Dividend Yield
- IOTR N/A
- COEP N/A
- EPS Growth
- IOTR N/A
- COEP N/A
- EPS
- IOTR N/A
- COEP N/A
- Revenue
- IOTR $10,478,550.00
- COEP $62,874.00
- Revenue This Year
- IOTR N/A
- COEP N/A
- Revenue Next Year
- IOTR N/A
- COEP N/A
- P/E Ratio
- IOTR N/A
- COEP N/A
- Revenue Growth
- IOTR 22.27
- COEP N/A
- 52 Week Low
- IOTR $0.31
- COEP $2.31
- 52 Week High
- IOTR $5.98
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- COEP 57.24
- Support Level
- IOTR N/A
- COEP $11.30
- Resistance Level
- IOTR N/A
- COEP $12.71
- Average True Range (ATR)
- IOTR 0.00
- COEP 0.91
- MACD
- IOTR 0.00
- COEP 0.09
- Stochastic Oscillator
- IOTR 0.00
- COEP 47.27
About IOTR IOTHREE LIMITED
iOThree Ltd is a provider of maritime digital technologies, including satellite connectivity and digitalization solutions in Singapore, focused on facilitating the maritime industry towards digital transformation. It offers shipboard infrastructure to customers by designing and installing the necessary satellite connectivity solution, IT equipment, shipboard equipment (such as equipment relating to navigation systems, automatic identification system, etc.), and JARVISS, a digitalization platform on the vessels of customers. The group's operating segments are: Satellite connectivity solution, which generates key revenue, and Digitalization and other solution. Geographically, it generates maximum revenue from Singapore, and rest from Israel, Malaysia, Vietnam, Thailand, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.